InsidersTradesSigma
Explore the detailed record of transactions filed by Rodino-Klapac Louise, Directeur Scientifique. Officer active across 1 companies, notably Sarepta Therapeutics, Inc.. Cumulatively, 6 reports have been published. Total volume traded: €533k. The latest transaction was disclosed on 4 March 2022 (Retenue fiscale). Regulator: SEC (Form 4). The full history is openly available.
6 of 6 declarations
Louise Rodino-Klapac is the Chief Scientific Officer and Head of R&D at Sarepta Therapeutics, Inc. She oversees the company's research and development activities, playing a key role in innovation and the development of new products. Her scientific expertise is essential to the company's mission.